C-Reactive Protein Testing Market Size, Share, Trends & Forecast
The C Reactive Protein Testing Market is expanding as healthcare providers place greater emphasis on inflammatory disease detection, chronic disease monitoring, and preventive healthcare. Market Research Future estimates the market at USD 3.196 billion in 2024 and projects it to reach USD 6.66 billion by 2035, representing a 6.9% CAGR during 2025–2035.
Growing awareness of inflammation as an important health indicator is supporting demand for CRP testing. Cardiovascular disease represents the largest application segment, reflecting the increasing use of inflammatory markers in cardiovascular assessment and related clinical strategies. Diabetes and other chronic conditions are also contributing to broader testing demand.
Technological advances are improving the accessibility and efficiency of CRP diagnostics. High-sensitivity assays can provide more precise measurements, while point-of-care testing enables faster results in settings outside conventional laboratories. These developments are supporting adoption among healthcare providers seeking efficient diagnostic workflows.
Preventive healthcare is another important growth factor. Healthcare systems are increasingly emphasizing earlier identification and management of disease risks rather than relying exclusively on treatment after symptoms become established. CRP testing could therefore become more integrated into selected health assessments and monitoring programs as awareness of inflammatory conditions increases.
With chronic disease prevalence increasing and diagnostic technologies continuing to evolve, the market is positioned for sustained expansion. Manufacturers that combine accuracy, rapid turnaround, automation, and cost efficiency may find significant opportunities as laboratories and healthcare facilities modernize their testing capabilities.
Gain a competitive edge with insightful market reports: